TransCode Therapeutics Inc (NASDAQ:RNAZ)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RNAZ

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RNAZ

  • Market Cap$0.000m
  • SymbolNASDAQ:RNAZ
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS89357L1052

Company Profile

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.

Latest RNAZ news

Currently there for this company. Visit our news hub for other news .